. 2021 Oct 28;CIR0000000000001029. doi: 10.1161/CIR.0000000000001029.
Gulati M, Peterson LA, Mihailidou A. Am J Prev Cardiol 2021 Oct 13;8:100280. doi: 10.1016/j.ajpc.2021.100280.
Mihailidou AS, Gulati M. Eur Heart J. 2021 Oct 18;ehab666. doi: 10.1093/eurheartj/ehab666
Bestseller by Dr. Martha Gulati and Ms Sherry Torkos
Please contact me for speaking engagements. Please note that I do not speak for pharmaceutical companies or promote any products.
From the American College of Cardiology
Evidence is mounting on the undertreatment of women with cardiovascular disease. Women face delays in recognition of disease and compared to men are less likely to receive guideline-directed medical therapy or the right intensification of therapy.
Explore how CVD presents differently in women and how to tailor treatment strategies based on physiological differences to optimize patient outcomes.